HTLV-II-related disease

Slower response to treatment of iron-deficiency anaemia in pregnant women infected with HIV: a prospective cohort study.

BJOG : an international journal of obstetrics and gynaecology·2021

Building capacities in research for blood services in Africa.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021

A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

Vox sanguinis·2017

[Role of quality control for improvement of blood components in the Regional Blood Centre of Ouagadougou in Burkina Faso, 2014].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2017

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections.

Genes and immunity·2017

Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm.

Vox sanguinis·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

Frontiers in bioengineering and biotechnology·2026

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Journal of medical education and curricular development·2026

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Frontiers in neurology·2026

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Frontiers in immunology·2026

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Frontiers in neuroscience·2026

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

Current cardiology reviews·2026

Related Experiment Videos

HTLV-II-related disease

Related Concept Videos

Slower response to treatment of iron-deficiency anaemia in pregnant women infected with HIV: a prospective cohort study.

Building capacities in research for blood services in Africa.

A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

[Role of quality control for improvement of blood components in the Regional Blood Centre of Ouagadougou in Burkina Faso, 2014].

Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections.

Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

Related Experiment Videos

HTLV-II-related disease

Related Concept Videos

Related Articles